De novo expression of functional connexins 43 and 45 hemichannels increases sarcolemmal permeability of skeletal myofibers during endotoxemia
dc.creator | Cea L.A. | |
dc.creator | Balboa E. | |
dc.creator | Vargas A.A. | |
dc.creator | Puebla C. | |
dc.creator | Brañes M.C. | |
dc.creator | Escamilla R. | |
dc.creator | Regueira T. | |
dc.creator | Sáez J.C. | |
dc.date.accessioned | 2020-09-02T22:14:47Z | |
dc.date.accessioned | 2022-11-08T20:23:18Z | |
dc.date.available | 2020-09-02T22:14:47Z | |
dc.date.available | 2022-11-08T20:23:18Z | |
dc.date.created | 2020-09-02T22:14:47Z | |
dc.date.issued | 2019 | |
dc.identifier | 1865, 10, 2765-2773 | |
dc.identifier | 09254439 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3981 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144786 | |
dc.language | en | |
dc.publisher | Elsevier B.V. | |
dc.subject | Connexons | |
dc.subject | LPS | |
dc.subject | Membrane permeability | |
dc.subject | Pro-inflammatory cytokines | |
dc.subject | Resting membrane potential | |
dc.subject | carbenoxolone | |
dc.subject | connexin 43 | |
dc.subject | connexin 45 | |
dc.subject | interleukin 1beta | |
dc.subject | lipopolysaccharide | |
dc.subject | tumor necrosis factor | |
dc.subject | calcium | |
dc.subject | connexin 43 | |
dc.subject | connexin 45 | |
dc.subject | cytokine | |
dc.subject | gap junction protein | |
dc.subject | glucocorticoid | |
dc.subject | lipopolysaccharide | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | controlled study | |
dc.subject | endotoxemia | |
dc.subject | male | |
dc.subject | membrane permeability | |
dc.subject | membrane steady potential | |
dc.subject | mouse | |
dc.subject | muscle tissue | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | protein expression | |
dc.subject | sarcolemma | |
dc.subject | skeletal muscle | |
dc.subject | animal | |
dc.subject | cell membrane | |
dc.subject | complication | |
dc.subject | disease model | |
dc.subject | drug effect | |
dc.subject | endotoxemia | |
dc.subject | genetics | |
dc.subject | knockout mouse | |
dc.subject | membrane potential | |
dc.subject | metabolism | |
dc.subject | pathology | |
dc.subject | permeability | |
dc.subject | skeletal muscle | |
dc.subject | Animals | |
dc.subject | Calcium | |
dc.subject | Cell Membrane | |
dc.subject | Connexin 43 | |
dc.subject | Connexins | |
dc.subject | Cytokines | |
dc.subject | Disease Models, Animal | |
dc.subject | Endotoxemia | |
dc.subject | Glucocorticoids | |
dc.subject | Lipopolysaccharides | |
dc.subject | Male | |
dc.subject | Membrane Potentials | |
dc.subject | Mice | |
dc.subject | Mice, Knockout | |
dc.subject | Muscle, Skeletal | |
dc.subject | Permeability | |
dc.title | De novo expression of functional connexins 43 and 45 hemichannels increases sarcolemmal permeability of skeletal myofibers during endotoxemia | |
dc.type | Article |